Integrative omics indicate FMRP sequesters mRNA from translation and deadenylation in human neuronal cells

Mol Cell. 2022 Dec 1;82(23):4564-4581.e11. doi: 10.1016/j.molcel.2022.10.018. Epub 2022 Nov 9.

Abstract

How fragile X syndrome protein (FMRP) binds mRNAs and regulates mRNA metabolism remains unclear. Our previous work using human neuronal cells focused on mRNAs targeted for nonsense-mediated mRNA decay (NMD), which we showed are generally bound by FMRP and destabilized upon FMRP loss. Here, we identify >400 high-confidence FMRP-bound mRNAs, only ∼35% of which are NMD targets. Integrative transcriptomics together with SILAC-LC-MS/MS reveal that FMRP loss generally results in mRNA destabilization and more protein produced per FMRP target. We use our established RIP-seq technology to show that FMRP footprints are independent of protein-coding potential, target GC-rich and structured sequences, and are densest in 5' UTRs. Regardless of where within an mRNA FMRP binds, we find that FMRP protects mRNAs from deadenylation and directly binds the cytoplasmic poly(A)-binding protein. Our results reveal how FMRP sequesters polyadenylated mRNAs into stabilized and translationally repressed complexes, whose regulation is critical for neurogenesis and synaptic plasticity.

Keywords: FMRP RIP-seq footprinting; SILAC-LC-MS/MS; deadenylation; fragile X syndrome protein; human neuroblastoma cells; mRNA decay; mRNA translation; poly(A)-binding protein; translationally silenced and stabilized FMRP-mRNA complexes.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, N.I.H., Extramural

MeSH terms

  • Chromatography, Liquid
  • Fragile X Mental Retardation Protein* / genetics
  • Fragile X Mental Retardation Protein* / metabolism
  • Fragile X Syndrome* / genetics
  • Humans
  • RNA, Messenger / genetics
  • RNA, Messenger / metabolism
  • Tandem Mass Spectrometry

Substances

  • Fragile X Mental Retardation Protein
  • RNA, Messenger